跳至主要内容
临床试验/NCT05208216
NCT05208216已完成不适用

Electronic Neuromuscular Stimulation Versus Intermittent pneumAtic Compression Devices for the pRevention of Venous Thromboembolic Disease in Critically Ill Adults: a Randomised Feasibility Study

Manchester University NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Successful application of the intervention

研究概览

简要总结

In this prospective, randomised, open-label, parallel group, feasibility trial; the investigators will objectively assess whether it is feasible to apply the Geko device to critically ill adults for the prevention of venous thromboembolism (VTE) compared to usual care with intermittent pneumatic compression devices (IPCs).

详细描述

VTE is a common problem amongst patients in critical care. Current measures include intermittent pneumatic compression devices, used to aid the venous return of blood from the lower limbs. These devices are contraindicated and/or poorly tolerated by some patients. Neuromuscular stimulation of the lower leg muscles might offer a better tolerated and more physiological alternative to IPCs.

In this feasibility trial the investigators will randomly allocate 40 patients to receive either the Geko device (n=20) or IPCs (n=20) as principal means of mechanical VTE prophylaxis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male or female aged ≥ 18 years.
  • •Intact healthy skin at the proposed site of gekoTM device application.
  • •Within 24 hours of their admission to critical care
  • •Expected to remain in critical care until the day after tomorrow

排除标准

  • •Use of any concurrent neuro-modulation drug or device (e.g. neuromuscular blocking agents).
  • •Trauma to the lower limbs that would prevent geko™ from stimulating the common peroneal nerve.
  • •Inability to palpate the fibula head in order to apply geko device effectively
  • •Inability to obtain valid written consent from the participant or their designated legal representative

研究组 & 干预措施

Intervention arm

Experimental

Application of the Geko device for mechanical VTE prophylaxis up until day 10 / discharge form critical care (whichever comes sooner).

干预措施: Geko device (Device)

Usual care arm

Active Comparator

Application of our usual intermittent pneumatic compression devices for mechanical VTE prophylaxis up until day 10 / discharge form critical care (whichever comes sooner).

干预措施: Flowtron DVT (Device)

结局指标

主要结局

Successful application of the intervention

时间窗: Daily measurements up to day 10 after enrolment

Objective measures of feasibility will include successful application of the intervention device. Investigators will make a daily assessment of whether the device is successfully applied to a participant or not. Successful application is defined as a device applied and producing a visible muscle twitch in the participant's lower leg. A predefined threshold of 70% or above would indicate feasibility of effective application of the intervention to trial participants.

次要结局

  • Venous return in the lower limbs(Baseline & day 3-5.)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验